Corrections
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5631 (Published 04 December 2017) Cite this as: BMJ 2017;359:j5631
In the article (BMJ 2017;359, doi:10.1136/bmj.j5058), instances of “rivaroxaban 20 mg twice daily” should read as “rivaroxaban 20 mg once daily” and “edoxaban 60 mg twice daily” as “edoxaban 60 mg once.”